Helmut Butzkueven

Cited by

	All	Since 2017
Citations	18581	10704
h-index	63	48
i10-index	190	171

2500

1250

625

1875

200420052006200720082009201020112012201320142015201620172018201920202021202278 94 143 189 239 289 479 493 756 993 1086 1348 1407 1433 1583 1736 2153 2476 1234

Public access

View all

98 articles

25 articles

available

not available

Based on funding mandates

Co-authors

Bruce V Taylormenzies Research Institute Tasmania University of TasmaniaVerified email at utas.edu.au
maria trojanoDipartimento di Scienze Mediche di Base, Neuroscienze ed Organi di Senso, Università degli StudiVerified email at uniba.it
Anneke Van Der WaltAssociate Professor, Central Clinical School, Monash UniversityVerified email at monash.edu
Gary EganMonash Biomedical Imaging, Monash UniversityVerified email at monash.edu
Ludwig KapposUniversity Hospital BaselVerified email at uhbs.ch
Scott KolbeMonash UniversityVerified email at monash.edu
Jeannette Lechner-ScottHunter Medical Research InstituteVerified email at health.nsw.gov.au
Justin Paul RubioAssociate Prof of Human Genetics, The Florey Institute of Neuroscience andVerified email at unimelb.edu.au
Vilija JokubaitisDepartment of Neuroscience, Monash UniversityVerified email at monash.edu
Ingrid van der MeiMenzies Institute for Medical Research, University of TasmaniaVerified email at utas.edu.au
Maria Pia SormaniUniversity of GenoaVerified email at unige.it
Gavin GiovannoniBarts and The London School of Medicine and DentistryVerified email at giovannoni.net
Michael BarnettThe University of Sydney / Brain and Mind CentreVerified email at sydney.edu.au
Melanie BahloTheme Leader, Healthy Development and Ageing, The Walter and Eliza Hall Institute ofVerified email at wehi.edu.au
Ben EmeryOregon Health and Science UniversityVerified email at ohsu.edu
Andrew EvansReta Lila Weston Institute and the Royal Melbourne HospitalVerified email at pobox.com
Shibeshih Mitiku BelachewBiogenVerified email at biogen.com
Mastura MonifSenior Post Doctoral Research Fellow (Dept of Neurosciences, Monash University), Neurologist (AlfredVerified email at monash.edu
Mark SleeFlinders University and Medical CentreVerified email at flinders.edu.au
Judith FieldResearch Scientist, CSL Ltd.Verified email at csl.com.au

Helmut Butzkueven

MSNI Research Group, Dept of Neuroscience, Central Clinical School, Monash University

Verified email at monash.edu

Multiple Sclerosis and Neuroimmunology


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis Nature 476 (7359), 214-219, 2011	2625	2011
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis International IBD Genetics Consortium (IIBDGC), C Agliardi, L Alfredsson, ... Nature genetics 45 (11), 1353-1360, 2013	1122	2013
Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity R Roxburgh, SR Seaman, T Masterman, AE Hensiek, SJ Sawcer, ... Neurology 64 (7), 1144-1151, 2005	936	2005
Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study IAF van der Mei, AL Ponsonby, T Dwyer, L Blizzard, R Simmons, ... Bmj 327 (7410), 316, 2003	690	2003
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study L Kappos, A Bar-Or, BAC Cree, RJ Fox, G Giovannoni, R Gold, ... The Lancet 391 (10127), 1263-1273, 2018	602	2018
Gait and balance impairment in early multiple sclerosis in the absence of clinical disability CL Martin, BA Phillips, TJ Kilpatrick, H Butzkueven, N Tubridy, ... Multiple Sclerosis Journal 12 (5), 620-628, 2006	595	2006
Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20 Data analysis: Bahlo Melanie 2 Brown Matthew A 6 7 Browning Brian L 20 ... Nature genetics 41 (7), 824-828, 2009	505	2009
Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia IAF van der Mei, AL Ponsonby, T Dwyer, L Blizzard, BV Taylor, T Kilpatrick, ... Journal of neurology 254 (5), 581-590, 2007	398	2007
Genome‐wide meta‐analysis identifies novel multiple sclerosis susceptibility loci NA Patsopoulos, ... Annals of neurology 70 (6), 897-912, 2011	327	2011
Brain health: time matters in multiple sclerosis G Giovannoni, H Butzkueven, S Dhib-Jalbut, J Hobart, G Kobelt, G Pepper, ... Multiple sclerosis and related disorders 9, S5-S48, 2016	313	2016
LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival H Butzkueven, JG Zhang, M Soilu-Hanninen, H Hochrein, F Chionh, ... Nature medicine 8 (6), 613-619, 2002	305	2002
Association of initial disease-modifying therapy with later conversion to secondary progressive multiple sclerosis JWL Brown, A Coles, D Horakova, E Havrdova, G Izquierdo, A Prat, ... Jama 321 (2), 175-187, 2019	267	2019
Defining secondary progressive multiple sclerosis J Lorscheider, K Buzzard, V Jokubaitis, T Spelman, E Havrdova, ... Brain 139 (9), 2395-2405, 2016	241	2016
Onset seizures independently predict poor outcome after subarachnoid hemorrhage H Butzkueven, AH Evans, A Pitman, C Leopold, DJ Jolley, AH Kaye, ... Neurology 55 (9), 1315-1320, 2000	235	2000
Geographical variations in sex ratio trends over time in multiple sclerosis M Trojano, G Lucchese, G Graziano, BV Taylor, S Simpson Jr, V Lepore, ... PLOS one 7 (10), e48078, 2012	222	2012
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis MS Stein, Y Liu, OM Gray, JE Baker, SC Kolbe, MR Ditchfield, GF Egan, ... Neurology 77 (17), 1611-1618, 2011	211	2011
Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial D Cadavid, L Balcer, S Galetta, O Aktas, T Ziemssen, L Vanopdenbosch, ... The Lancet Neurology 16 (3), 189-199, 2017	203	2017
MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis H Butzkueven, J Chapman, E Cristiano, F Grand’Maison, M Hoffmann, ... Multiple Sclerosis Journal 12 (6), 769-774, 2006	172	2006
Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results H Butzkueven, L Kappos, F Pellegrini, M Trojano, H Wiendl, RN Patel, ... Journal of Neurology, Neurosurgery & Psychiatry 85 (11), 1190-1197, 2014	168	2014
Switch to natalizumab versus fingolimod in active relapsing–remitting multiple sclerosis T Kalincik, D Horakova, T Spelman, V Jokubaitis, M Trojano, A Lugaresi, ... Annals of Neurology 77 (3), 425-435, 2015	159	2015

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow this author

Cited by

Co-authors